Research has shown that one biochemical pathway likely to be relevant but not yet extensively studied in NAFLD is the eicosanoid generating lipoxygenases pathway 12-LOX [28]. Here, SPRR2A is linked to metabolic dysfunction-associated steatotic liver disease.